Mirati Therapeutics (MRTX) Earnings Date, Estimates & Call Transcripts

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)

Notice: This company has been marked as potentially delisted and may not be actively trading.

Stock Analysis Analyst Forecasts Earnings Headlines Insider Trades Ownership Short Interest Social Media Sustainability

MRTX Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

MRTX Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

Ad Gold Safe Exchange

The “Perfect Storm” for Gold

Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.

Click here now to download the free Precious Metals Buying Guide!

Mirati Therapeutics Analyst EPS Estimates

Current Year EPS Consensus Estimate:($11.39) EPS
Next Year EPS Consensus Estimate: ($9.81) EPS

Mirati Therapeutics Earnings History by Quarter

Time Frame

Start Date

End Date

Export to Excel

Date	Quarter	Consensus Estimate	Reported EPS	Beat/Miss	GAAP EPS	Revenue Estimate	Actual Revenue
11/6/2023	Q3 2023	($2.83)	($2.49)	+$0.34	($2.49)	$18.80 million	$16.40 million
8/8/2023	Q2 2023	($3.23)	($3.04)	+$0.19	($3.04)	$13.17 million	$13.70 million
5/9/2023	Q1 2023	($3.47)	($3.18)	+$0.29	($3.18)	$4.80 million	$7.17 million
2/28/2023	Q4 2022	($3.74)	($3.51)	+$0.23	($3.51)	$2.65 million	$0.93 million
11/8/2022	Q3 2022	($3.46)	($3.09)	+$0.37	($3.09)	$4.72 million	$5.43 million
8/3/2022	Q2 2022	($3.53)	($3.18)	+$0.35	($3.18)	$2.20 million	$5.36 million
Get the Latest News and Ratings for MRTX and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Mirati Therapeutics and its competitors with MarketBeat's FREE daily newsletter.
5/4/2022	Q1 2022	($3.37)	($3.40)	($0.03)	($3.40)	$0.18 million	$0.71 million
2/28/2022	Q4 2021	($3.01)	($3.72)	($0.71)	($3.72)	$1.41 million	$0.30 million
11/8/2021	Q3 2021	($2.87)	($1.55)	+$1.32	($1.55)	$1.41 million	$71.79 million
8/5/2021	Q2 2021	($2.40)	($3.23)	($0.83)	($3.23)	-	-
5/6/2021	Q1 2021	($2.13)	($2.67)	($0.54)	($2.67)	$0.17 million	$0.01 million

Mirati Therapeutics Earnings - Frequently Asked Questions

How much revenue does Mirati Therapeutics generate each year?: Mirati Therapeutics (NASDAQ:MRTX) has a recorded annual revenue of $12.44 million.
How much profit does Mirati Therapeutics generate each year?: Mirati Therapeutics (NASDAQ:MRTX) has a recorded net income of -$740.87 million. MRTX has generated -$12.22 earnings per share over the last four quarters.
What is Mirati Therapeutics's EPS forecast for next year?: Mirati Therapeutics's earnings are expected to grow from ($11.39) per share to ($9.81) per share in the next year.

More Earnings Resources from MarketBeat

Related Companies:

Earnings Tools:

Earnings By Country:

Latest Articles:

This page (NASDAQ:MRTX) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Mirati Therapeutics (MRTX) Earnings Date, Estimates & Call Transcripts

MRTX Earnings Estimates and Actuals by Quarter

MRTX Estimated and Actual Revenue by Quarter

Mirati Therapeutics Analyst EPS Estimates

Mirati Therapeutics Earnings History by Quarter

Mirati Therapeutics Earnings - Frequently Asked Questions

More Earnings Resources from MarketBeat

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info